Synthesis and structures of zinc complexes with new binucleating ligands containing alkoxide bridges, and their activities in the hydrolysis of tris(p-nitrophenyl)phosphate

Four new binucleating ligands featuring a hydroxytrimethylene linker between two coordination sites (1,3-bis{N-[3-(dimethylamino)propyl]-N-methylamino}propan-2-ol, HL¹; 1,3-bis{N-[2-(dimethylamino)ethyl]-N-methylamino}propan-2-ol, HL²; 1,3-bis[bis(2-methoxyethyl)amino]propan-2-ol, HL³; and 1-bis[(2-methoxyethyl)amino]-3-{N-[2-(dimethylamino)ethyl]-N-methylamino}propan-2-ol, HL⁴) were synthesized, along with the corresponding zinc complexes. The structures of three dinuclear zinc complexes ([Zn₂L¹(μ-CH₃COO)₂]BPh₄ (1), [Zn₂L³(μ-CH₃COO)₂]BPh₄ (3), and [Zn₂L⁴(μ-CH₃COO)(CH₃COO)(EtOH)]BPh₄ (4)) and a tetranuclear zinc complex ({[Zn₂L²(μ-CH₃COO)]₂(μ-OH)₂}(BPh₄)₂ (2)) were revealed by X-ray crystallography. Hydrolysis of tris(p-nitrophenyl)phosphate (TNP) by these zinc complexes in an acetonitrile solution containing 5% Tris buffer (pH 8.0) at 30 °C was investigated spectrophotometrically and by ³¹P NMR. Although zinc complexes 1, 3, and 4 did not show hydrolysis activity, the tetranuclear zinc complex 2, containing μ-hydroxo bridges, was capable of hydrolyzing TNP. This suggests that the hydroxide moiety in the complex may have an important role in the hydrolysis reaction.     

Copper(II) and zinc(II) complexes with Schiff-base ligands derived from salicylaldehyde and 3-methoxysalicylaldehyde: Synthesis,crystal structures,magnetic and luminescence properties

The following Schiff bases were employed as ligands in synthesizing copper(II) and zinc(II) complexes: N-[(2-pyridyl)-methyl]-salicylimine (Hsalampy), N-[2-(N,N-dimethyl-amino)-ethyl]-salicylimine (Hsaldmen), and N-[(2-pyridyl)-methyl]-3-methoxy-salicylimine (Hvalampy). The first two ligands were obtained by reacting salicylaldehyde with 2-aminomethyl-pyridyne and N,N-dimethylethylene diamine, respectively, while the third one results from the condensation of 3-methoxysalicylaldehyde with 2-aminomethyl-pyridine. Four new coordination compounds were synthesized and structurally characterized: [Cu(salampy)(H₂O)(ClO₄)] 1, [Cu₂(salampy)₂(H₂trim)₂] 2 (H₂trim^? = the monoanion of the trimescic acid), [Cu₄(valampy)₄](ClO₄)₄ · 2CH₃CN 3, and [Zn₃(saldmen)₃(OH)](ClO₄)₂ · 0.25H₂O 4. The crystal structure of 1 consists of supramolecular dimers resulted from hydrogen bond interactions established between mononuclear [Cu(salampy)(H₂O)(ClO₄)] complexes. Compound 2 is a binuclear complex with the copper ions connected by two monoatomic carboxylato bridges arising from two molecules of monodeprotonated trimesic acid. The crystal structure of 3 consists of tetranuclear cations with a heterocubane {Cu₄O₄} core, and perchlorate ions. Compound 4 is a trinuclear complex with a defective heterocubane structure. The magnetic properties of complexes 1–3 have been investigated. Compound 4 exhibits solid-state photoluminescence at room temperature.     

Syntheses and structures of four- and five-coordinate bio-related zinc complexes containing dithiolate-diamine ligands

Two new zinc complexes, namely, [{Zn(N₂H₂S₂)}₂] (3) [N₂H₂S₂²⁻ = N,N-bis(2-mercaptophenyl)ethylendiamine (2−)] and [Zn(N₂Me₂S₂)] (4) [N₂Me₂S₂²⁻ = N,N′-dimethyl-N,N′-bis(2-mercaptophenyl)ethylendiamine) (2−)] have been synthesized and structurally characterized by X-ray structure analyses. The structure of 3 consists of a bis(μ-thiolato) binuclear unit, in which each zinc center was found to reside in an N₂S₃ array between square-pyramidal and trigonal-bipyramidal environment. The two zinc centers are bridged by one of the two thiolates of an [N₂S₂] ligand. In the crystal packing, the neighboring binuclear units interact with each other by H-bonding interaction, which extends the binuclear unit into a 3D network. In contrast to 3 complex 4 is mononuclear, where each zinc center now was found to reside in an N₂S₂ distorted tetrahedral environment with a large S-Zn-S bite angle. The relevance of these compounds in biological systems is discussed. Unlike 3, the formation of hydrogen bridges in 4 is no longer possible and instead the molecular packing is determined by π-stacking between the phenyl rings.     

Manganese(II) complexes of a set of 2-aminomethylpyridine-derived ligands bearing a methoxyalkyl arm: syntheses, structures and magnetism

Four new ligands, N-(2-methoxyethyl)-N-(pyridin-2-ylmethyl)amine (mepma), N-(3-methoxypropyl)-N,N-bis(pyridin-2-ylmethyl)amine (mpbpa), N-(2-methoxyethyl)-N,N-bis(pyridin-2-ylmethyl)amine (mebpa) and 2-{[(2-methoxyethyl)(pyridin-2-ylmethyl)amino]methyl} phenol (Hmepap), and four of their complexes with manganese(II) halides, [MnCl₂(mepma)₂] (1), [MnCl(μ-Cl)(mpbpa)]₂ (2), [MnBr₂(mebpa)] (3) and [MnBr₂(MeOH)(Hmepap)] (4) have been synthesized and characterized. Single-crystal Xray studies revealed that in all four complexes, the Mn(II) coordination spheres are distorted octahedral. In 1 and 2, the ether oxygen atom does not coordinate to the Mn(II) centre, but in 3 and 4 it does. The mononuclear molecules of 1 are linked by double hydrogen bonds to form linear chains. Temperature dependent magnetic susceptibility measurements revealed that the Mn(II) ions in 1 interact antiferromagnetically, with J=−1.06 cm⁻¹. Compound 2 crystallizes as a double chloride-bridged dimer in which there is a weak ferromagnetic interaction (J=0.55 cm⁻¹) between the Mn(II) pair. The solution EPR spectrum of 2 suggests that in methanol compound 2 decomposes to a great extent to mononuclear species. In compound 3, mebpa acts as a tetradentate ligand with all of its nitrogen and oxygen atoms coordinated to the Mn(II) ion. Unexpectedly, in complex 4, the phenolic oxygen of Hmepap remains protonated and does not coordinate to the metal ion. Instead the oxygen from a methanol molecule coordinates the manganese centre. Hydrogen bonds between one of the two bromide ions, and the methanol and phenol hydroxyl groups, respectively, connect the mononuclear molecules of 4 into chains. No magnetic interactions were observed between the Mn(II) ions in 3 or 4.     

Substituted pyridylmethylamide ligands and their zinc complexes

Mononuclear zinc complexes of a family of pyridylmethylamide ligands abbreviated as HL, HL^Ph, HL^Me3, HL^Ph3, and MeL^SMe [HL = N-(2-pyridylmethyl)acetamide; HL^Ph = 2-phenyl-N-(2-pyridylmethyl)acetamide; HL^Me3 = 2,2-dimethyl-N-(2-pyridylmethyl)propionamide; HL^Ph3 = 2,2,2-triphenyl-N-(2-pyridylmethyl)acetamide; MeL^SMe = N-methyl-2-methylsulfanyl-N-pyridin-2-ylmethyl-acetamide] were synthesized and characterized spectroscopically and by single crystal X-ray structural analysis. The reaction of zinc(II) salts with the HL ligands yielded complexes [Zn(HL)₂(OTf)₂] (1), [Zn(HL)₂(H₂O)](ClO₄)₂ (2), [Zn(HL^Ph3)₂(H₂O)](ClO₄)₂ (3), [Zn(HL^Ph)Cl₂] (4), [Zn(HL^Me3)Cl₂] (5), and [Zn(MeL^SMe)Cl₂] (6). The complexes are either four-, five- or six-coordinate, encompassing a variety of geometries including tetrahedral, square-pyramidal, trigonal-bipyramidal, and octahedral.     

Nickel(II) complexes of terdentate or symmetrical tetradentate Schiff bases: Evidence of the influence of the counter anions in the hydrolysis of the imine bond in Schiff base complexes

Two sets of ligands, set-1 and set-2, have been prepared by mixing 1,3-diaminopentane and carbonyl compounds (2-acetylpyridine or pyridine-2-carboxaldehyde) in 1:1 and 1:2 ratios, respectively, and employed for the synthesis of complexes with Ni(II) perchlorate, Ni(II) thiocyanate and Ni(II) chloride. Ni(II) perchlorate yields the complexes having general formula [NiL₂](ClO₄)₂(L = L¹ [N³-(1-pyridin-2-yl-ethylidene)-pentane-1,3-diamine] for complex 1 or L²[N³-pyridin-2-ylmethylene-pentane-1,3-diamine] for complex 2) in which the Schiff bases are monocondensed terdentate, whereas Ni(II) thiocyanate results in the formation of tetradentate Schiff base complexes, [NiL(SCN)₂] (L = L³[N,N′-bis-(1-pyridin-2-yl-ethylidine)-pentane-1,3-diamine] for complex 3 or L⁴ [N,N′-bis(pyridin-2-ylmethyline)-pentane-1,3-diamine] for complex 4) irrespective of the sets of ligands used. Complexes 5 {[NiL³(N₃)₂]} and 6 {[NiL⁴(N₃)₂]} are prepared by adding sodium azide to the methanol solution of complexes 1 and 2. Addition of Ni(II) chloride to the set-1 or set-2 ligands produces [Ni(pn)₂]Cl₂, 7, as the major product, where pn = 1,3-diaminopentane. Formation of the complexes has been explained by the activation of the imine bond by the counter anion and thereby favouring the hydrolysis of the Schiff base. All the complexes have been characterized by elemental analyses and spectral data. Single crystal X-ray diffraction studies confirm the structures of three representative members, 1, 4 and 7; all of them have distorted octahedral geometry around Ni(II). The bis-complex of terdentate ligands, 1, is the mer isomer, and complexes 4 and 7 possess trans geometry.     

Synthesis,structures and urease inhibitory activity of cobalt(III) complexes with Schiff bases

A series of new cobalt(III) complexes were prepared. They are [CoL¹(py)₃]·NO₃ (1), [CoL²(bipy)(N₃)]·CH₃OH (2), [CoL³(HL³)(N₃)]·NO₃ (3), and [CoL⁴(MeOH)(N₃)] (4), where L¹, L², L³ and L⁴ are the deprotonated form of N′-(2-hydroxy-5-methoxybenzylidene)-3-methylbenzohydrazide, N′-(2-hydroxybenzylidene)-3-hydroxylbenzohydrazide, 2-[(2-dimethylaminoethylimino)methyl]-4-methylphenol, and N,N′-bis(5-methylsalicylidene)-o-phenylenediamine, respectively, py is pyridine, and bipy is 2,2′-bipyridine. The complexes were characterized by infrared and UV–Vis spectra, and single crystal X-ray diffraction. The Co atoms in the complexes are in octahedral coordination. Complexes 1 and 4 show effective urease inhibitory activities, with IC₅₀ values of 4.27 and 0.35 μmol L⁻¹, respectively. Complex 2 has medium activity against urease, with IC₅₀ value of 68.7 μmol L⁻¹. While complex 3 has no activity against urease. Molecular docking study of the complexes with Helicobacter pylori urease was performed.     

Synthesis and characterization of a chiral Schiff base containing α-d-altropyranoside unit and its zinc(II) complex

A novel chiral Schiff base containing α-d-altropyranoside unit, methyl 4,6-O-benzylidene-3-deoxy-3-(2-salicylideneaminoethylamino)-α-d-altropyranoside (3, Me-Alt-NNOH), has been prepared. Treatment of zinc chloride with 3 in the presence of triethylamine afforded a five-coordinated zinc(II) complex [Zn(Me-Alt-NNO)Cl] (4). Both 3 and 4 have been characterized by infrared, ¹H NMR, ¹³C NMR, MS, and elemental analysis. The crystal structure of 4 has been determined by X-ray diffraction. Crystal structure analysis shows that the complex 4 exits a distorted triangular bipyramid geometry and the Schiff base motif acts as a uninegatively charged tetradentate chelating agent. The methoxy and amino groups cis-chelate to the zinc atom and the pyrano-ring is in an ideal ⁴C₁ chair conformation.     

Structural variety and stereochemical features of bis(diphenylphosphinyl)[3]ferrocenophane gold(I) complexes

The P,N-[3]ferrocenophane ligand 3 forms a (κP-ligand)AuCl complex (5) upon treatment with (Me₂S)AuCl. The corresponding P,P-[3]ferrocenophane system 4 yields a binuclear (κP,κP-chelate ligand)(AuCl)₂ complex (6) when reacted with 2 equivalents of the (Me₂S)AuCl reagent. Complex 6 features an intramolecular aurophilic Au?Au interaction. Treatment of the P,P-[3]ferrocenophane 4 with 1.0 equiv. of (PPh₃)AuCl gives the tetra-coordinated mono-gold(I) complex (P,P-ligand)(PPh₃)AuCl (7), whereas the cationic [(P,P-ligand)₂Au]⁺[Cl⁻] system is obtained from 4 and 0.5 equivalents of (Me₂S)AuCl. The [(P,P-ligand)₂Au]⁺ system is obtained in different diastereoisomeric forms (8 and 9) depending on the stereochemistry of the pair of P,P-[3]ferrocenophane chelate ligand used. Examples of the complexes 5, 6, 7 and 8 were characterized by X-ray diffraction.     

Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[18F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide,a potent pyridazinoindole ligand for PET imaging of TSPO in cancer

A novel synthesis of the translocator protein (TSPO) ligand 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide (SSR180575, 3) was achieved in four steps from commercially available starting materials. Focused structure–activity relationship development about the pyridazinoindole ring at the N3 position led to the discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide (14), a novel ligand of comparable affinity. Radiolabeling with fluorine-18 (¹⁸F) yielded 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[¹⁸F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide ([¹⁸F]-14) in high radiochemical yield and specific activity. In vivo studies of [¹⁸F]-14 revealed this agent as a promising probe for molecular imaging of glioma.     

Design,synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT7 receptor

Here we describe the design, synthesis, and pharmacological evaluation of a set of compounds structurally related to the high affinity serotonin 5-HT₇ receptor agonist N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide (6, LP-211). Specific structural modifications were performed in order to maintain affinity for the target receptor and to improve the selectivity over 5-HT_1A and adrenergic α₁ receptors. The synthesized compounds have chemical features that could enable labeling with a positron emitter radioisotope (carbon-11 or fluorine-18) and lipophilicity within the range considered optimal for brain penetration and low non-specific binding. 4-[2-(4-Methoxyphenyl)phenyl]-N-(pyridin-4-ylmethyl)piperazinehexanamide (23a) and N-pyridin-4-ylmethyl-3-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]propanamide (26a) were radiolabeled on the methoxy group with carbon-11. Positron emission tomography (PET) analysis revealed that [¹¹C]-23a and [¹¹C]-26a were P-glycoprotein (P-gp) substrates and rapidly metabolized, resulting in poor brain uptake. These features were not predicted by in vitro tests.     

Hexanuclear copper(II) complex of a novel poly(pyridine) ligand exhibiting unique long distance ferromagnetic interactions through a nitrato-O,O bridge

A novel hexanuclear copper complex [Cu₆(NO₃)₁₂(opytrizediam)₂(H₂O)][(CH₃)₂CO]_0.5(CH₃CH₂CH₂OH)_0.5 (1) with a NO₃ bridge has been synthesized by reaction of Cu(NO₃)₂ · 3H₂O with the new potentially octadentate ligand opytrizediam in n-propanol/acetone solution (opytrizediam=N,N^′-{2,4-di[(di-pyridin-2-yl)amine]-1,3,5-triazine} ethylenediamine). A single-crystal X-ray diffraction analysis showed the presence of six structurally different copper centres. The coordination spheres of four copper(II) ions are best described as square-pyramidal CuN₂O₃ chromophores while the two other copper(II) ions are in a trigonal-bipyramidal CuN₄O environment. Variable-temperature studies on 1 revealed a unique ferromagnetic coupling of two copper(II) ions bridged by a didentate nitrate anion and separated by a distance of 6.391(6) Å, with J=8.6(1) cm⁻¹.     

Zinc(II) tweezers containing artificial peptides mimicking the active site of phosphotriesterase: The catalyzed hydrolysis of the toxic organophosphate parathion

Two new ligand-containing histidine based on N,N′,N″-tris(N-benzyl-l-histidinyl)tri(2-aminoethyl)amine, L¹, namely N,N′,N″-tris[(1S)-2-methoxy-2-oxy-1-(1-benzylimidazol-4-ylmethyl)]nitrilotriacetamide L² and N,N′,N″-tris{N-benzyl-N-[N-benzyl-N-(N-benzyl-l-histidinyl)-l-histidinyl]-l-histidinyl}tri(2-aminoethyl)amine L³ were prepared. Zinc(II) binding studies by these ligand systems were analyzed by means of potentiometric and ¹H NMR titrations in aqueous methanol (33 % v/v). Subsequently their zinc(II) complexes [L¹Zn(H₂O)](ClO₄)₂·HClO₄ (1), [L²Zn(OH₂)](ClO₄)₂·H₂O (2), and ([L³Zn₃(H₂O)₃](ClO₄)₆·3HClO₄·5H₂O (3), respectively were synthesized and characterized. The reactivity of the trinuclear complex (3) toward the hydrolysis of the toxic organophosphate parathion was investigated and compared with that of the mononuclear reference complex (1). From the pH dependence of the apparent rate constants, and the deprotonation constant (pK_a) of the coordinated water molecules in (1), the active species were confirmed to be {[HL¹Zn(OH)]²⁺/[L¹Zn(H₂O)]²⁺} at pH 8.5. The trizinc complex (3) effects hydrolysis of parathion, with three times rate enhancement over the mononuclear (1), indicating that cooperative action of the three zinc centers is limited.     

Synthesis, characterization, crystal structures and magnetic properties of dissymmetrical double schiff base heterotrinuclear complexes: [CuL(H2O)CoCuL] · H2O · CH3OH and [(CuL)2Ni] · 2H2O

A dissymmetrical double Schiff base Cu(II) mononuclear complex: CuHL (1) (where H₃L is N-3-carboxylsalicylidene-N^′-salicylaldehyde-1,2-diaminoethane) and two trinuclear complexes: [CuL(H₂O)CoCuL] · H₂O · CH₃OH (2) and [(CuL)₂Ni] · 2H₂O (3) have been synthesized and characterized by means of elemental analyses, IR and electronic spectra. The crystal structures of two heterotrinucler complexes were determined by X-ray analysis. Each dissymmetrical cell unit of the complex 2 contains two heterotrinucler neutral molecules. In each neutral molecule, the central Co²⁺ ion is located at the site of O₆ with a distorted octahedral geometry and one terminal Cu²⁺ ion at the four-coordination site of N₂O₂, but the other one at the square-pyramidal environment of N₂O₃. Each dissymmetrical unit of the complex 3 contains a heterotrinucler neutral molecule, whose structure is similar to that of 2 except two terminal Cu²⁺ ions both at the inner site of N₂O₂. The magnetic properties of two heterotrinucler complexes have been determined in the temperature range of 5-300 K, which indicate that the interaction between the central Co²⁺ ion or Ni²⁺ ion and the outer Cu²⁺ ions is antiferromagnetic. The exchange integrals are equal to −26.2 cm⁻¹ for 2 and −50.6 cm⁻¹ for 3.     

Diverse reactivity of stereoisomers containing quadruply bonded dimolybdenum with oxygen: formation of [{Mo(η-N,N′-diisopropylbenzamidinato)oxo}2(μ-acetato)2(μ-oxo)]

The reaction of quadruply bonded dimolybdenum complex, [Mo₂(μ-OAc)₄] (1), with lithiated amidinato, Li[(NⁱPr)₂CR] (R = ^tBu; 2a, Me; 2b, Ph; 2c), was investigated. The reaction of 1 with 2a afforded the dark-red solid, whereas the product was so highly unstable that the product was not able to be characterized. In the case of acetamidinato 2b, lantern-type mixed-ligand quadruply bonded dimolybdenum complex, [Mo₂(μ-OAc){μ-(NⁱPr)₂CMe}₃] (3), was obtained as a yellow solid. In the reaction with benzamidinato 2c, symmetrical lantern-type dimolybdenum complex, [Mo₂(μ-OAc)₂ {μ-(NⁱPr)₂CPh}₂] (4), was isolated as a yellow solid. In the latter reaction, intermediary red compound (5), which is considered to be stereoisomer of 4 possessing non-lantern-type skeleton, was formed. However, isolation of 5 as a single component was not successful due to isomerization to 4. Complex 5 readily reacted with dry oxygen to give dimolybdenum(V) complex, [{Mo(η-(NⁱPr)₂CPh)oxo}₂ (μ-OAc)₂(μ-oxo)] (6), as a red solid. These complexes were characterized spectroscopically as well as, in some cases, by X-ray analyses.     

Studies of rheniumtricarbonyl complexes of tripodal pyridyl-based ligands

The reaction of N-benzoyl and N-acetyl tris(pyridin-2-yl)methylamine 1b and 1c (LH = tpmbaH and tpmaaH) with [Re(CO)₅Br] has been investigated and shown to proceed via the initial formation of a cationic rheniumtricarbonyl complex [(LH)Re(CO)₃]Br in which coordination of the ligand occurs via the three pyridine rings. For tpmbaH 1b, but not tpmaaH 1c, this initial complex 2b readily undergoes the loss of HBr to give a neutral octahedral complex 4b [(L)Re(CO)₃] where coordination occurs via two of the pyridine rings and the deprotonated amide nitrogen. The ¹H NMR spectrum of the latter complex 4b is very unusual in that at room temperature the signals for the 3-H protons on the coordinated pyridine rings are not visible due to extreme broadening of these resonances. Comparison with the analogous complex 7 from N-benzoyl bis(pyridin-2-yl)methylamine 6b (bpmbaH) confirms that this is due to rotation of the uncoordinated pyridine ring. The structure of the cationic complex 3d [(LH)Re(CO)₃]Br formed from N-benzyl tris(pyridin-2-yl)methylamine 1d (bz-tpmaH) is also discussed. The crystal structures of complexes [(tpmba)Re(CO)₃] 4b, [(bz-tpmaH)Re(CO)₃]Br 3d and [(bpmba)Re(CO)₃] 7 have been determined. In all complexes the coordination geometry around Re is distorted octahedral with a fac-{Re(CO)₃}⁺ core.     

Solution and solid state behavior of Co2+, Ni2+ and Zn2+ tosylaminoacidate systems: Crystal and molecular structure of bis(N-tosylglycinato)tetraaquocobalt(II) and bis(N-tosyl-β-alaninato)tetraaquozinc(II) complexes

The interactions between N-tosylamino acids and cobalt(II), nickel(II) and zinc(II) ions in aqueous solution and in the solid state have been investigated. From concentrated aqueous solutions, compounds of general formula [M(II)(N-tosylaminoacidato)₂(H₂O)₄](M = Co(II), Ni(II) and N-tosylaminoacidato = N-tosylglycinate (Tsgly^?), N-tosyl-α- and -β-alaninate (Ts-α- and Ts-β-ala^?); M = Zn(II) and N-tosylaminoacidate = Tsgly^?, Ts-β-ala^?) and [Zn(II)(N- tosylaminoacidato)₂(H₂O)₂] were isolated and characterized by means of thermogravimetric, electronic and infrared spectra. For two of them: [Co(Tsgly)₂(H₂O)₄](I) and [Zn(Ts-β-ala)₂(H₂O)₄](II) the crystal and molecular structures were also determined. Both compounds crystallize in the monoclinic space group P2₁/c, with two formula units in a cell of dimensions: a = 13.007(6), b = 5.036(2), c = 18.925(7) Å, β = 102.33(3)° for (I) and a = 14.173(6), b = 5.469(2), c = 17.701(7) Å, β = 106.63(3)° for (II). The structures were solved by the heavy-atom method and refined by least-squares calculations to R = 0.031 and 0.064 for (I) and (II) respectively. The cobalt and zinc atoms lie in the centers of symmetry, each bonded to two amino- acid molecules through a carboxylic oxygen atom and four water molecules in a slightly tetragonally distorted octahedral geometry. The second carboxylic oxygen atom is not involved in metal coordination. Electronic and X ray-powder spectra suggest that the tetrahydrate complexes of Co²⁺, Ni²⁺ and Zn²⁺ ions of the same amino acids are isomorphous and isostructural. No coordinative interactions between ligand and metal ions were found in aqueous solution on varying the pH values before hydroxide precipitation.     

Five-coordinate zinc(II) complexes with optically active Schiff bases derived from (1R,2R)-(−)cyclohexanediamine: X-ray structure and CP MAS NMR characterization of [cyclohexylenebis(5-chlorosalicylideneiminato)zinc(II)pyridine] and [cyclohexylenebis(5-bromosalicylideneiminato)zinc(II)pyridine]

Schiff bases obtained from (1R,2R)-(−)-cyclohexanediamine and 5-chloro- (1) or 5-bromosalicylaldehyde (2) are used as ligands for Zn(II) resulting in [(1R,2R)-cyclohexylenebis(5-chlorosalicylideneiminato)]zinc(II) (1a) and (1R,2R)-[cyclohexylenebis-(5-bromosalicylideneiminato)]zinc(II) (2a). In the presence of pyridine, 1a and 2a turned out into (1R,2R)-[cyclohexylenebis(5-chlorosalicylideneiminato)pyridine]zinc(II) (1b) and (1R,2R)-[cyclohexylenebis(5-bromosalicylideneiminato)pyridine]zinc(II) (2b). Coordination sphere of Zn(II) atoms in both pyridine adducts is a slightly distorted square pyramid, with N₂O₂ chromophore units and axially bonded pyridine as it is evident from single crystal X-ray analyzes of 1b and 2b. The asymmetric unit of 1b and 2b contains two molecules of complexes. The observed distances of Zn-O in both molecules indicate the rigidity of the tetradentate ligand as a main factor influencing the geometry of coordination sphere. Obtained complexes were characterized by ¹H NMR in solution and ¹³C CP MAS NMR. NOE differential experiments revealed significant steric interactions between C(6)-H in the phenyl ring, cyclohexyl C(1)-H and imine hydrogen. Significant coordination shifts of carbons in the closest proximity to the coordination center were noted as well.     

A new sterically loaded pentadentate N3S2 ligand and its zinc complexes

In quest of complexes having [MN₃S₂] cores in the monomeric form and trans-thiolate donor atoms, the new pentadentate thiolate amine py^tBuN₂H₂S₂-H₂ [] has been synthesized.The template condensation reaction of bis(2-mercapto-3,5-di-tert-butylaniline)zinc (II)[Zn(^tBu₂ma)₂] and pyridine-2,6-dicarbaldehyde in methanol at 40 °C leads to the formation of imine zinc complex [Zn(py^tBuN₂S₂)] (7), which is very unstable and decomposes to give thiazole 5. However, if the template condensation is followed by in situ reduction with an excess of NaBH₄, the stable saturated amine complex [Zn(py^tBuN₂H₂S₂)] (8) is formed. Demetallation of zinc complex 8 under acidic conditions leads to the formation of the desired dithiolate py^tBuN₂H₂S₂-H₂ ligand (9).     

Facile synthesis of carbon-11-labeled cholesterol-based cationic lipids as new potential PET probes for imaging of gene delivery in cancer

Gene therapy based on gene delivery is a promising strategy for the treatment of various human diseases such as cancer. Cationic lipids represent one of the important synthetic gene delivery systems. There is a great interest in imaging of gene therapy using the biomedical imaging technique positron emission tomography (PET). Carbon-11-labeled cholesterol-based cationic lipids were first designed and synthesized as new potential PET probes for imaging of gene delivery in cancer. The [¹¹C-methyl]quaternary amine target tracers, N-[¹¹C]methyl-N-[4-(cholest-5-en-3β-yloxycarbonyl)butyl]pyrrolidinium iodide ([¹¹C]4a), N-[¹¹C]methyl-N′-[4-(cholest-5-en-3β-yloxycarbonyl)butyl]imidazolium iodide ([¹¹C]4b), N-[¹¹C]methyl-N-[4-(cholest-5-en-3β-yloxycarbonyl)butyl]piperidinium iodide ([¹¹C]4c), N-[¹¹C]methyl-N-[4-(cholest-5-en-3β-yloxycarbonyl)butyl]-4-methylpiperidinium iodide ([¹¹C]4d), and N-[¹¹C]methyl-N-[4-(cholest-5-en-3β-yloxycarbonyl)butyl]morpholinium iodide ([¹¹C]4e), were prepared from their corresponding tertiary amine precursors with [¹¹C]methyl iodide ([¹¹C]CH₃I) through N-[¹¹C]methylation and isolated by a simplified solid-phase extraction (SPE) method using a Silica Sep-Pak cartridge in 50-60% radiochemical yields decay corrected to end-of-bombardment (EOB), based on [¹¹C]CO₂, and 111-185 GBq/μmol specific activity at the end of synthesis (EOS).